Afatinib and osimertinib in lung adenocarcinoma harbored EGFR T751_I759delinsS mutation: A case report

Tyrosine kinase inhibitors (TKIs) of epidermal growth factor receptor (EGFR) are the standard treatment for lung cancer patients with activating EGFR mutation. The traditional direct polymerase chain reaction (PCR) has lower sensitivity in the detection of EGFR mutations in patient tissue samples. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yueh‐Fu, Liu, Ping‐Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671894/
https://www.ncbi.nlm.nih.gov/pubmed/34729927
http://dx.doi.org/10.1111/1759-7714.14215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671894/
https://www.ncbi.nlm.nih.gov/pubmed/34729927
http://dx.doi.org/10.1111/1759-7714.14215

Ejemplares similares